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SUMMARY
NuMA is a 236 kDa protein that participates in the organization of the mitotic spindle despite its strict localization
in the nucleus during interphase. To test how cells progress
through mitosis when NuMA is localized in the cytoplasm
instead of the nucleus, we have deleted the nuclear localization sequence of NuMA using site-directed mutagenesis
and transiently expressed this mutant protein (NuMA∆NLS) in BHK-21 cells. During interphase, NuMA-∆NLS
accumulates in the cytoplasm as a large mass approximately the same size as the cell nucleus. When cells enter
mitosis, NuMA-∆NLS associates normally with the mitotic
spindle without causing any apparent deleterious effects on
the progression of mitosis. Examination of the cytoplasmic
mass formed by NuMA-∆NLS using transmission electron
microscopy (TEM) revealed an extensive network of ~5 nm

filaments that are further organized by the presence of
dynamic microtubules into a dense web of solid, ~23 nm
cables. Using flow cytometry, we have isolated the intact filamentous mass formed by NuMA-∆NLS from lysates of
transiently transfected cells. These isolated structures are
constructed of networks of interconnected 5 nm filaments
and are composed exclusively of NuMA. These data
demonstrate that NuMA is capable of assembling into an
extensive filamentous structure supporting the possibility
that NuMA serves a structural function either in the
nucleus during interphase or at the polar ends of the
mitotic spindle.

INTRODUCTION

to be excluded from the nucleoli (Price and Pettijohn, 1986,
Compton et al., 1991; Kallajoki et al., 1991; Tousson et al.,
1991; Yang et al., 1992; Maekawa et al., 1991). When the
nuclear envelope disassembles during prometaphase, NuMA is
released from the nuclear compartment and accumulates at the
polar end of the mitotic spindle. The prevailing evidence
suggests that once NuMA is released from the nucleus and
accumulates at the mitotic spindle pole it plays an essential role
in organizing the microtubules at the polar region of the mitotic
spindle. Experimental support for this functional role include
the perturbation of the organization of the mitotic spindle
following the microinjection of NuMA-specific antibodies
(Gaglio et al., 1995; Kallajoki et al., 1991, 1992, 1993; Yang
and Snyder, 1992), the elimination of microtubule organization
in a cell free mitotic extract following the specific depletion of
NuMA (Gaglio et al., 1995), and the perturbation of the organization of the mitotic spindle following the expression of a
mutant form of the NuMA protein that fails to associate with
the mitotic spindle and exerts dominant negative phenotype
(Compton and Luo, 1995).
The possible functional role(s) for NuMA in the nucleus,
however, are much less certain due to the lack of defined functional assays for specific nuclear function. It has been proposed
that NuMA is a structural component of the core fibers of the

The nucleus of a typical vertebrate cell undergoes extensive
physical rearrangement during mitosis (Newport and Forbes,
1987; Gerace and Burke, 1988). These structural changes are
necessary for the efficient segregation of the nuclear components into each of the daughter cells, and examples of these
physical rearrangements include the condensation of the chromosomes, the dissolution of the nuclear lamina, and the vesicularization of the nuclear envelope. To date, there appear to be
three segregation pathways for the components of the nucleus
during mitosis. The chromosomes and chromatin-associated
proteins are segregated equally into each daughter cell during
anaphase through their association with the microtubules of the
mitotic spindle (Mitchison, 1989; Rieder, 1991). The nuclear
envelope vesicles, nuclear lamina, and many other nuclear
proteins are distributed into each daughter cell by passive
diffusion (McKeon, 1991; Nigg, 1992; Wiese and Wilson,
1993). Finally, the NuMA protein is distributed equally into
each daughter cell through its association with the polar ends
of the mitotic spindle (Lyderson and Pettijohn, 1980; reviewed
by Compton and Cleveland, 1994; Cleveland, 1995).
NuMA is a 236 kDa protein that is distributed uniformly
throughout the interior of the cell nucleus although it appears
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nuclear matrix (Yang et al., 1992; Zeng et al., 1994a), that it
participates in the re-assembly of the daughter cell nuclei at the
end of mitosis (Compton and Cleveland, 1993), and that it is
a component of splicing complexes (Zeng et al., 1994b). In
addition to these proposed specific functions for NuMA within
the cell nucleus, there have also been proposals that NuMA is
only localized in the nucleus to sequester it away from the cytoplasmic microtubules during the interphase stages of mitosis
(Compton et al., 1992). Indeed, we have recently proposed that
the localization of NuMA in the nucleus establishes an inherent
asymmetry to its distribution which is necessary for its role in
directing the microtubules of the developing mitotic spindle
toward the chromosomes during assembly of the mitotic
spindle (Compton and Luo, 1995).
Given the strict localization of NuMA in the nucleus during
interphase, and the proposals that NuMA may only be
localized in the cell nucleus to sequester it away from the cytoplasmic microtubules we decided to examine how cells
progress through mitosis if NuMA is present in the cell
cytoplasm instead of the nucleus. The amino acid sequence
necessary and sufficient for NuMA’s localization in the
nucleus has been mapped to a short segment in its carboxylterminal globular tail domain (Tang et al., 1994). To test the
fate of NuMA in the cell cytoplasm we have used site-directed
mutagenesis to delete the nuclear localization sequence from
the NuMA protein and then transiently expressed this mutant
form of NuMA (NuMA-∆NLS) in BHK-21 cells. In this article
we show that NuMA-∆NLS accumulates in the cell cytoplasm
in a filamentous mass approximately the same size as the cell
nucleus, and that NuMA-∆NLS associates normally with the
microtubules of the mitotic spindle without exerting any
dominant negative effects. The cytoplasmic structure formed
by NuMA-∆NLS is composed of an extensive network of ~5
nm filaments that become organized into solid ~23 nm cables
in the presence of dynamic microtubules. These results demonstrate that NuMA is capable of assembling into an extensive
filamentous array consistent with the proposed structural roles
for NuMA in the interphase nucleus and at the polar ends of
the mitotic spindle.
MATERIALS AND METHODS
Cell culture
The hamster BHK-21 cell line was maintained in DME containing
10% fetal calf serum, 2 mM glutamine, 100 i.u./ml penicillin, and 0.1
µg/ml streptomycin. Cells were grown at 37°C in a humidified
incubator with a 5% CO2 atmosphere.
Transfection and microinjection
Cells were transiently transfected using Lipofectamine reagent (Gibco
BRL/Life Technologies, Gaithersberg, MD) as described by the manufacturer. Cells growing on 35 mm dishes with (for immunofluorescence and electron microscopy) or without (for immunoblot
analysis) glass coverslips were washed twice, and equilibrated in 800
µl Opti-MEM serum free medium. Plasmid DNA (1 µg) diluted in
100 µl of Opti-MEM serum free medium, and 10 µg of the Lipofectamine reagent diluted in 100 µl of Opti-MEM serum free medium
were mixed and incubated at room temperature for 15 to 20 minutes.
The DNA/lipid complex contained in 200 µl was then added to the
cells dropwise while mixing. The cells were then incubated at 37°C

for 6 to 8 hours, and then washed twice and incubated overnight with
complete medium.
Cells growing on photo etched alpha-numeric glass coverslips
(Bellco Glass Co., Vineland, NJ) were microinjected following the
procedures of Compton and Cleveland (1993) and Capecchi (1980).
Interphase cells were microinjected in the nucleus with plasmid DNA
at a concentration of 100 µg/ml in 10 mM Tris-HCl, pH 7.4, 1 mM
EDTA. Injected cells were followed by phase contrast microscopy and
processed for immunofluorescence and electron microscopy.
Immunological techniques
Intracellular localization of expressed human NuMA in the hamster
cell line BHK-21 was determined following procedures outlined by
Compton et al. (1991). Cells growing on glass coverslips were
extracted and fixed by immersing the coverslips in microtubule stabilizing buffer (MTSB: 4 M glycerol, 100 mM Pipes, pH 6.8, 1 mM
EGTA, 5 mM MgCl2) for 1 minute at room temperature followed by
extraction with MTSB containing 0.5% Triton X-100 at room temperature for 2 minutes, rinsing in MTSB for 2 minutes at room temperature, and finally fixing in −20°C methanol for 10 minutes. Cells
were rehydrated using TBS (10 mM Tris-HCl, pH 7.5, 150 mM NaCl)
containing 1% bovine serum albumin and all subsequent steps were
performed in TBS containing 1% bovine serum albumin at room temperature. In some cases the cells were fixed without prior detergent
extraction by immersion in phosphate-buffered saline containing
3.5% paraformaldehyde for 5 minutes at room temperature. The cells
were then extracted with 0.5% Triton X-100 in TBS containing 1%
bovine serum albumin for 5 minutes at room temperature. Following
fixation, primary antibodies were added to the cells and incubated for
30 minutes at room temperature in a humidified chamber. Coverslips
were washed in TBS containing 1% bovine serum albumin and the
bound antibodies were detected with the appropriate fluorescein-conjugated or Texas red-conjugated secondary antibodies (Vector labs,
Burlingame, CA). DNA was detected with 4′,6-diamidino-2phenylindole (DAPI, 0.4 µg/ml; Sigma Chemical Co., St Louis, MO).
Coverslips were mounted in FITC-Guard (Testog, Chicago, IL) and
observed with a Nikon Optiphot microscope equipped for epifluorescence. No fewer than 12 cells were examined for each panel presented
in Figs 2-4, and the panels shown depict a representative cell for each
experiment.
Proteins were analyzed from transiently transfected cells by
immunoblot analysis following SDS-PAGE (Laemmli, 1970). Cells
were washed three times in ice-cold PBS and harvested directly in
SDS-PAGE sample buffer. Proteins were separated by size by SDSPAGE and transferred to PVDF membrane (Millipore Corp., Bedford
MA). This membrane was blocked in TBS containing 5% nonfat milk
for 30 minutes at room temperature, and the primary antibody
incubated for 6 hours at room temperature in TBS containing 1%
nonfat milk. Non-bound primary antibody was removed by washing
five times for 3 minutes each in TBS and the bound antibody was
detected using horseradish peroxidase-conjugated Protein A (Bio-Rad
Co., Hercules CA). Non-bound Protein A was removed by washing
five times for 3 minutes each in TBS and the bound Protein A was
detected using enhanced chemiluminescence (Amersham Corp.,
Arlington Heights, IL).
Site-directed mutagenesis
The full length 7.2 kb human NuMA cDNA was transferred from the
bluescript plasmid (Compton and Cleveland, 1993) into the multiple
cloning site of the pUC19 plasmid vector in the same 5′ to 3′ orientation as the β-galactosidase gene using the unique BamHI site and
the SalI sites (Compton and Luo, 1995). This plasmid was maintained
in the DH1 strain of Escherichia coli and purified by CsCl centrifugation (Maniatis et al., 1982). Mutation of the NuMA cDNA was
performed using the transformer site-directed mutagenesis kit
(Clontech laboratories Inc., Palo Alto CA) precisely as described by
the manufacturer. The sequence of the mutagenic primer (Operon
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Technologies Inc., Alameda CA) was 5′-GTGGGGCTCTAGGGAGACCCGGGTGGTGATGCCAGTGC-3′. This oligonucleotide
creates an internal deletion of 15 nucleotides in the human NuMA
cDNA that eliminates amino acid residues 1971-1975 (1985-1989
using the amino acid numbering system of Yang et al., 1992). This
oligonucleotide also introduces a novel SmaI site into the cDNA that
permits rapid identification of the mutant clones. The appropriate
mutation was verified by DNA sequence analysis, and no multiple
mutations occurred as judged by restriction analysis using the
mutation-associated restriction enzyme site. Following mutagenesis,
the 7.2 kb EcoRI fragment containing the full length NuMA cDNA
was transferred into the unique EcoRI site of the multiple cloning site
of the mammalian expression vector GW1CMV. These plasmids were
maintained in the DH1 strain of E. coli and purified by CsCl centrifugation.
Electron microscopy
Cells growing on photo etched alpha-numeric glass coverslips
expressing NuMA-∆NLS were identified by phase contrast
microscopy. The coverslips were removed from the culture medium
and the cells fixed with 2% glutaraldehyde in 0.1 M Na-cacodylate
buffer, pH 7.4, for 1 hour at room temperature either with or without
(as indicated in the text) prior extraction with MTSB containing 0.5%
Triton X-100. Following fixation, the cells were rinsed in 0.1 M Nacacodylate buffer, post-fixed with 1% OsO4 in 0.1 M Na-cacodylate
buffer for 30 minutes at room temperature, and en-bloc stained in 2%
aqueous uranyl acetate. Cells were dehydrated through a graded series
of ethanols and propylene oxide, and flat-embedded in
epon(LX112)/araldite(502). The glass coverslip was removed by
etching in cold concentrated hydrofluoric acid as described by Moore
(1975), and Rieder and Bowser (1987). The area of interest was identified with the help of a dissecting microscope, cut out of the flatembedded rectangle and remounted onto epoxy blanks. Sections (6070 nm) were prepared and stained with 2% uranyl acetate in methanol
for 20 minutes followed by 5 minutes in Reynold’s lead citrate.
Micrographs were taken at 80 or 100 kV on a JEOL 100CX. No fewer
than four cells were examined for each panel in Figs 5 and 6, and the
panels shown depict a representative cell for each experiment.
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expressed human NuMA protein by immunoblot analysis
following transient transfection of hamster BHK-21 cells (Fig.
1). In BHK-21 cells transfected with the expression vector
alone (containing no cDNA; Fig. 1, Mock) there is no
detectable protein when analyzed using a primate-specific antiNuMA rabbit polyclonal antibody (Gaglio et al., 1995). In
BHK-21 cells transfected with the expression plasmid driving
the expression of either the wild-type human NuMA protein
(Fig. 1, NuMA 1-2101) or NuMA-∆NLS (Fig. 1, NuMA∆NLS) a single protein is detected that migrates with a
molecular mass >200 kDa. These data are consistent with
previous experiments involving the expression of human
NuMA in the context of hamster BHK-21 cells (Compton and
Cleveland, 1993; Compton and Luo, 1995), and indicate that
NuMA-∆NLS migrates in SDS-PAGE with the same relative
molecular mass as the wild-type human NuMA protein.
To determine the intracellular localization of NuMA-∆NLS
we performed indirect immunofluorescence microscopy using
the primate-specific anti-NuMA rabbit serum (Gaglio et al.,
1995) and the tubulin-specific monoclonal antibody DM1α
(Fig. 2). In interphase cells that express NuMA-∆NLS but have
not yet passed through mitosis the human NuMA protein accumulates in a large mass adjacent to the nucleus in the cell
cytoplasm. This cytoplasmic mass formed by NuMA-∆NLS is
frequently similar in size to the cell nucleus, and careful
focusing of the microscope indicates that it is fibrous in nature
(Fig. 2A). In addition to these qualities, the cytoplasmic structures formed by NuMA-∆NLS consistently stain positive for
tubulin although the microtubule array in other regions of the
cytoplasm do not appear to be affected in any noticeable way.
The morphology of the cytoplasmic mass formed by NuMA∆NLS is identical regardless of the fixation condition
(methanol, paraformaldehyde, glutaraldehyde) or whether the

Flow cytometry
BHK-21 cells were harvested 18 to 24 hours after transfection with
the plasmid driving the expression of NuMA-∆NLS. The cells were
removed from the culture dish by trypsinization, washed twice with
PBS, and lysed at a concentration of 1.5×106 cells/ml by agitation in
lysis buffer (20 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM MgCl2,
0.25 M sucrose, 0.5% Triton X-100, 20 µg/ml PMSF, 1 µg/ml each
of leupeptin, pepstatin, antipain, and DAPI) for 1 hour at 4°C. The
crude lysate was then subjected to flow cytometry with phosphatebuffered saline as the vehicle using a FACStar Plus (Becton
Dickinson). The data was collected and analyzed using the Lysys II
software package.

RESULTS
Expression of human NuMA in the cell cytoplasm
To determine the functional properties of NuMA when it accumulates in the cell cytoplasm rather than in the cell nucleus we
have used site-directed mutagenesis to delete five amino acids
(15 nucleotides) from the globular tail of the NuMA protein.
These five amino acids span the core of NuMA’s nuclear localization sequence based on the previous results of Tang et al.
(1994). To verify that the mutant NuMA cDNA (NuMA∆NLS) is competent to drive the expression of a protein with
the appropriate molecular mass, we determined the size of the

Fig. 1. Expression of human NuMA in hamster BHK-21 cells. The
primate-specific anti-NuMA rabbit antibody was used to detect the
exogenously expressed human NuMA proteins in ~40 µg of total cell
extract after electrophoresis on a 5% SDS-polyacrylamide gel. BHK21 cells were transfected with the expression vector alone (Mock), or
the expression vector driving the expression of either the full length
human NuMA protein (NuMA 1-2,101) or the NuMA lacking the
nuclear localization sequence (NuMA-∆NLS). The migration
positions of myosin (200 kDa), β-galactosidase (116 kDa), and
phosphorylase B (97 kDa) are indicated at the left.
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cells are fixed directly or subjected to extraction with non-ionic
detergents prior to fixation under conditions that either
preserve microtubules or conditions for the observation of the
nuclear matrix. Moreover, we observed that NuMA-∆NLS
formed a filamentous structure in the cell cytoplasm whether
the expression level is relatively high (Fig. 3A) or low (Fig.
3B), and in all cases these filamentous structures stained positively for tubulin if they were assembled in the presence of
dynamic microtubules. Finally, while the localization of
NuMA-∆NLS to the cell cytoplasm is probably the direct result
of the mutation we introduced into the NuMA cDNA, the
assembly of NuMA into a filamentous mass in the cell
cytoplasm is not an artifact of the expression of a mutant form
of NuMA because we have observed similar structures in the
cytoplasm of cells expressing extremely high levels (approximately 5% of transfected cells) of the wild-type human NuMA
protein (data not shown). These results verify that amino acids
1971-1975 form the core of NuMA’s nuclear localization
sequence (Tang et al., 1994), and further show that the accumulation of NuMA in the cell cytoplasm leads to the formation
of a mass that has fibrous qualities which are detectable by
immunofluorescence microscopy.
When cells expressing NuMA-∆NLS enter mitosis, the
human NuMA-∆NLS protein localizes normally at the polar
ends of the mitotic spindle although the staining intensity at
the spindle poles is reproducibly weaker than the staining

Fig. 2. Localization of human NuMA∆NLS in BHK-21 cells. Cells were
transiently transfected with the plasmid
driving the expression of NuMA lacking
the nuclear localization sequence. Cells in
interphase prior to mitosis (A), during
mitosis (B) or in interphase following the
completion of mitosis (C) were fixed and
processed for immunofluorescence
microscopy with the DNA-specific dye
(DAPI), the primate-specific anti-NuMA
rabbit serum (NuMA), and the tubulinspecific mouse monoclonal antibody
DM1α (Tubulin). Note that the
magnification in A and B is different from
C. Bars, 20 µm.

intensity of the cytoplasmic mass that forms prior to mitosis
(Fig 2B). Following the completion of mitosis, the human
NuMA-∆NLS protein accumulates in the nuclei of the two
daughter cells (Fig. 2C). The most likely explanation for the
post-mitotic nuclear accumulation of NuMA-∆NLS is that it
interacts with the endogenous hamster NuMA protein during
mitosis and the nuclear localization sequence on the endogenous protein acts in a dominant fashion to direct the nuclear
accumulation of the human NuMA-∆NLS following mitosis.
Regardless of the mechanism of post-mitotic nuclear import of
NuMA-∆NLS, these data indicate that despite the accumulation of NuMA-∆NLS in the cell cytoplasm prior to mitosis, this
mutant form of NuMA localizes correctly during other phases
of mitosis and does not exert any observable dominant negative
effect on the assembly of the mitotic spindle or the progression of mitosis.
Because the cytoplasmic structures formed by NuMA-∆NLS
appear to have a filamentous nature and they stain positively
for tubulin we tested if the assembly of these structures
required microtubules. For this experiment we transiently
expressed the human NuMA-∆NLS protein in the hamster cells
and then perturbed the cytoplasmic array of microtubules using
either taxol or nocodazole. To test if microtubules were
necessary to maintain these cytoplasmic structures we allowed
NuMA-∆NLS to accumulate and assemble into the cytoplasmic mass prior to the addition of either taxol or nocodazole.

Filamentous assembly of NuMA
Under these conditions, the addition of the microtubule perturbing drugs has little effect on the organization of the
structure formed by NuMA-∆NLS in the cell cytoplasm (data
not shown). To test if microtubules are necessary for the
assembly of the cytoplasmic mass of NuMA-∆NLS we added
either taxol or nocodazole to the culture medium during the
expression of the NuMA-∆NLS protein in the cell cytoplasm.
For this experiment we microinjected the plasmid DNA
directly into the cell nucleus to induce protein expression,
allowed the cells to recover from the microinjection at 37°C
for 15 minutes, and then added either taxol or nocodazole to
the culture medium (each at 10 µM for 8 hours). In the
presence of taxol, NuMA-∆NLS still accumulates in the perinuclear region of the cytoplasm as a solid mass, but it no
longer has a filamentous quality nor does it stain positively for
tubulin (Fig. 3C). In the presence of nocodazole, NuMA-∆NLS
accumulates in a ring-like aggregate around the nucleus in

Fig. 3. Localization of various quantities of
human NuMA-∆NLS in BHK-21 cells and
localization of NuMA-∆NLS in BHK-21 cells
in the presence of either taxol or nocodazole.
Cells were either transiently transfected (A,B)
or microinjected (C,D) with the plasmid
driving the expression of NuMA lacking the
nuclear localization sequence. Cells were fixed
directly (A,B) or treated with either 10 µM
taxol (C) or 10 µM nocodazole (D) for 8 hours
and then fixed and processed for
immunofluorescence microscopy with the
DNA-specific dye (DAPI), the primate-specific
anti-NuMA rabbit serum (NuMA), and the
tubulin-specific mouse monoclonal antibody
DM1α (Tubulin). Bar, 20 µm.
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addition to a number of foci dispersed throughout the
cytoplasm. These structures lack any obvious filamentous
quality observable by immunofluorescence microscopy, but
contrary to the results using taxol, these NuMA-∆NLS foci do
stain positively for tubulin (Fig. 3D). These results indicate that
NuMA-∆NLS accumulates in discrete foci in the cell
cytoplasm regardless of the presence of microtubules, but that
dynamic microtubules are necessary during the accumulation
of NuMA-∆NLS for the cytoplasmic mass to attain the fibrous
quality that is detectable by immunofluorescence microscopy.
Next, we examined whether other cytoskeletal components
localize in the NuMA-∆NLS structure (Fig. 4). Using Texas redconjugated phalloidin to identify actin and an antibody specific
for vimentin (the only intermediate filament protein expressed
in BHK-21 cells) we failed to detect either vimentin or actin
associated with the NuMA-∆NLS structure (Fig. 4A,B). Indeed,
the structure formed by NuMA-∆NLS, like the nucleus, appears
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to exclude a majority of the cytoplasmic intermediate filaments
(Fig. 4B). Next, because of the shape of the NuMA-∆NLS
structure we tested if the nuclear lamins associated with NuMA∆NLS. Using an antibody that recognizes both lamin A and C
(courtesy of Dr L. Gerace) we failed to detect any association
of the nuclear lamin proteins A or C with the NuMA-∆NLS
structure in the cytoplasm (Fig. 4C). Finally, we tested for the
presence of the centrosome using antibodies specific for pericentrin (courtesy of Dr S. Doxsey). Despite the accumulation of
NuMA-∆NLS in the perinuclear region of the cell there is no
consistent association of this structure with the centrosome (Fig.
4D, arrow). Taken together, these results indicate that no other
cytoskeletal proteins appear to be associated with the cytoplasmic structure formed by NuMA-∆NLS, and suggest that the
fibrous quality of the cytoplasmic mass formed by NuMA-∆NLS
that is observable by immunofluorescence microscopy is derived
from an interaction between NuMA and dynamic microtubules.

Fig. 4. Localization of human NuMA-∆NLS
relative to other cytoskeletal systems in BHK21 cells. Cells were transiently transfected with
the plasmid driving the expression of NuMA
lacking the nuclear localization sequence. Cells
were fixed and processed for
immunofluorescence microscopy with the
DNA-specific dye (DAPI), the NuMA-specific
monoclonal antibody 1F1 (NuMA), and either
Texas red-conjugated phalloidin (A), a rabbit
antibody recognizing vimentin (B), a rabbit
antibody recognizing nuclear lamins A and C
(C), or a rabbit antibody recognizing the
centrosome-associated protein pericentrin (D).
Bar, 20 µm.

Ultrastructure of NuMA in the cell cytoplasm
The apparent filamentous organization of the structures formed
by NuMA in the cell cytoplasm prompted us to examine these
structures at high magnification using transmission electron
microscopy (TEM). For these experiments we grew the BHK21 cells on photo-etched gridded coverslips, transfected them
with the plasmid that drives the expression of NuMA-∆NLS,
and then used phase contrast microscopy to select the cells to
examine by TEM. When viewed by TEM the filamentous
nature of the cytoplasmic mass created by the expression of
NuMA-∆NLS is clearly obvious (Fig. 5A). A large region of
the cytoplasm adjacent to the nucleus is occupied by a dense
web of solid, unbranching cables that extend up to 2 µm in
length (the actual length of each cable may be longer, but thin
section prohibits their observation), and appear to exclude
adjacent components of the cytoplasm (i.e. mitochondria). At
high magnification (Fig. 5B, large arrow), the solid core of

Filamentous assembly of NuMA
each cable is clearly visible when viewed in cross section or
viewed laterally and is uniformly ~23 nm in diameter
(23.01±1.03 nm). Unlike typical cytoskeletal filaments,

Fig. 5. Ultrastructure on
NuMA-∆NLS expressed in
the cytoplasm of BHK-21
cells. Cells were
transiently transfected with
the plasmid driving the
expression of NuMA
lacking the nuclear
localization sequence and
either fixed directly (A-C)
or extracted with a
microtubule stabilizing
buffer containing 0.5%
Triton X-100 prior to
fixation (D,E) in 2%
glutaraldehyde. Cells were
then dehydrated,
embedded, sectioned, and
viewed by transmission
electron microscopy. Large
arrows indicate cables
observed in cross section,
and small arrows indicate
regions of lateral
asymmetry. Bars: (A,D), 1
µm; (B,C,E), 200 nm.

Fig. 6. Ultrastructure on NuMA∆NLS expressed in the cytoplasm
of BHK-21 cells in the presence
of microtubule perturbing drugs.
Cells were microinjected with the
plasmid driving the expression of
NuMA lacking the nuclear
localization sequence and treated
with either 10 µM nocodazole
(A,B) or 10 µM taxol (C,D) for 8
hours. Cells were then extracted
with a microtubule stabilizing
buffer containing 0.5% Triton X100, fixed in 2% glutaraldehyde,
processed, and viewed by
transmission electron microscopy.
Bars: (A,C), 1 µm; (B,D), 200 nm.
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however, these cables are laterally asymmetric. Both the lateral
and the cross sectional views reveal that each cable has a
smooth side and an electron dense ‘fuzzy’ side (Fig. 5B, small
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arrows). Consistent with the results obtained with immunofluorescence microscopy, the filamentous assembly of NuMA∆NLS in the cell cytoplasm is not an artifact arising from the
expression of a mutant form of NuMA, because we have
observed similar filamentous structures by TEM in the
cytoplasm of a minority of transfected cells that are expressing extremely high levels of the wild-type NuMA protein (data
not shown). Finally, we failed to find any microtubules within
this mass of NuMA-derived cables despite the fact that
immunofluorescence analysis indicates that tubulin is present
within this mass and that microtubules were visible in the
adjacent regions of the cell cytoplasm (Fig. 5C).
Extraction of the cells with Triton X-100 in a microtubule
stabilizing buffer prior to fixation and processing for electron
microscopy provides an enhanced view of the filamentous
nature of the cytoplasmic mass formed by NuMA-∆NLS (Fig.
5D). Under these conditions, the cytoplasmic mass formed by
NuMA is primarily composed of two types of filamentous
structures (Fig. 5E), and despite the exclusion of a majority of
the cytoplasmic intermediate filaments from this filamentous
mass (e.g. Fig. 4B) a few intermediate filaments are observable scattered throughout the NuMA-∆NLS mass. One type of
filament has the same morphology as the cables observed when
cells are fixed directly without any prior detergent extraction.

These cables are up to 2 µm long, solid, unbranching, ~23 nm
in diameter, and laterally asymmetric (Fig. 5E, large arrow).
The other type of filament has a diameter of ~5 nm (4.80±0.67
nm), is highly branching, and appears to form a dense network
that interconnects the larger cables. Indeed, the electron dense
‘fuzzy’ side of the 23 nm cables that was observed in cells
prepared for TEM without prior detergent extraction appear to
be composed of these 5 nm filaments (Fig. 5E, large and small
arrows). These structures are resistant to extraction with high
salt, because the same complex organization of ~23 nm cables
interconnected by ~5 nm filaments is observed if the cells
expressing NuMA-∆NLS were extracted under conditions
suitable for the observation of the nuclear matrix prior to
fixation and examination by TEM (extraction conditions of He
et al., 1990; data not shown). Finally, as in the cells fixed
directly in glutaraldehyde without prior detergent extraction,
no microtubules are visible within this cytoplasmic mass
despite the presence of microtubules in adjacent regions of the
cytoplasm (data not shown).
Since immunofluorescence analysis suggests that the filamentous nature of the mass formed by NuMA-∆NLS is
dependent on the presence of dynamic microtubules, we
examined the ultrastructure of the products formed by
expression of NuMA-∆NLS in the presence of either taxol or

Fig. 7. Isolation of NuMA∆NLS-containing structures.
(A) BHK-21 cells were
transiently transfected with
either the expression
plasmid driving the
expression of NuMA
lacking the nuclear
localization sequence
(NuMA-∆NLS) or the
empty expression vector
(Mock), a lysate prepared
from each cell population
with the addition of 1 µg/ml
DAPI, and subjected to flow
cytometry using the
parameters of UV intensity
(x axis) and light scattering
intensity (y axis). The
indicated window was used
to sort the light scattering
particles with low UV
intensity. (B) Following
flow cytometry the selected
particles were spotted onto
poly-L-lysine coated
coverslips, fixed, and
processed for
immunofluorescence
microscopy using the
primate-specific anti-NuMA
rabbit serum (NuMA) and
the tubulin-specific mouse monoclonal antibody DM1α (Tubulin). Bar, 20 µm. (C) Approximately 100,000 particles selected by flow
cytometry were solubilized in SDS sample buffer and fractionated by size on a 7.5% SDS-polyacrylamide gel. The gel was stained with
Coomassie blue and the migration position of myosin (200), β-galactosidase (116), phosphorylase B (97), bovine serum albumin (66), and
ovalbumin (45) are indicated on the left in kDa. (D) Immunoblot analysis with the primate-specific anti-NuMA rabbit serum (NuMA), the
tubulin-specific mouse monoclonal antibody DM1α (Tubulin), or the rabbit antibody recognizing vimentin (Vimentin) of approximately 5,000
flow cytometry-selected particles (lane 1), or total cell protein from approximately 15,000 BHK-21 cells that have been transiently transfected
with either the empty expression plasmid (lane 2) or the plasmid driving the expression of NuMA-∆NLS (lane 3).
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Fig. 8. Ultrastructure of the
purified structures formed by
expression of NuMA-∆NLS in
the cytoplasm of BHK-21. The
structures formed by NuMA∆NLS were purified by flow
cytometry, spotted onto poly-Llysine coated coverslips, fixed
in 2% glutaraldehyde,
processed, and viewed by
transmission electron
microscopy. Bars: (A,C), 1 µm;
(B,D), 200 nm.

nocodazole (Fig. 6). In the presence of nocodazole (Fig. 6A,B)
NuMA-∆NLS accumulates in a ring-like aggregate surrounding
the nucleus in addition to multiple foci dispersed throughout the
cytoplasm. This cytoplasmic mass is composed of a collection
of electron dense foci that are interconnected by a complex
network of ~5 nm filaments whose morphology is similar to the
~5 nm filaments observed in cells expressing NuMA-∆NLS in
the absence of any microtubule perturbing drugs. There are no
detectable cables resembling the ~23 nm cables that are observed
when the protein is assembled in the presence of dynamic microtubules and no microtubules are observed in these cells. In the
presence of taxol (Fig. 6C,D) NuMA-∆NLS formed a mass in
the cytoplasm adjacent to the nucleus that is substantially denser
and less extended compared to when it assembles in the presence
of dynamic microtubules or in the presence of nocodazole.
Similar to the structure formed by NuMA-∆NLS in the presence
of nocodazole, the mass formed by NuMA-∆NLS in the
presence of taxol is composed of a regular array of electron
dense foci interconnected by a network of 5 nm filaments that
lack both the 23 nm cables and microtubules although bundles
of microtubules were clearly visible at the periphery of the
structure. These results suggest that the ~23 nm cables are
derived from an interaction between dynamic microtubules and
the expressed human NuMA-∆NLS protein, and that the fibrous
quality of the cytoplasmic mass formed by NuMA-∆NLS that is
observable by immunofluorescence microscopy is due to the
formation of these ~23 nm cables.
To determine if any other cellular proteins participate with
NuMA-∆NLS in the assembly of these cytoplasmic structures
we have devised a strategy using flow cytometry to purify the
intact structures as if they were individual organelles. BHK-21
cells are transiently transfected with the plasmid to express

NuMA-∆NLS and the transfected cells are harvested and lysed
with Triton X-100. Under these conditions, the cytoplasmic
structures formed by NuMA-∆NLS remain intact as judged by
both phase contrast and immunofluorescence microscopy (data
not shown). We adapted the technique of flow cytometry to the
isolation of these structures because the intact structures are
large enough to be identified as particles by light scattering and
they consistently co-purified with intact nuclei during conventional sedimentation-based protocols. Thus, we used flow
cytometry to sort the intact structures formed by NuMA-∆NLS
away from the nuclei using the parameters of UV intensity (for
DNA stained with DAPI) and light scattering intensity. In a
typical flow cytometry analysis ~2.5% of the total number of
light scattering particles appear in the selection window
indicated in the plot following expression of NuMA-∆NLS
(Fig. 7A, NuMA-∆NLS) whereas only 0.07% of the total light
scattering particles are found in the analogous selection
window following transfection with the expression plasmid
alone (Fig. 7A, mock).
The structures isolated by this flow cytometry technique
retain the morphology of the mass formed by NuMA-∆NLS
that is observed by immunofluorescence microscopy and TEM
in vivo and are ~5-10 µm in diameter. The isolated structures
stain positively for NuMA but do not stain positively for
tubulin (Fig. 7B) suggesting that any tubulin that was associated with the structures in vivo is lost during the isolation
procedure. To determine what proteins are contained in these
isolated structures we solubilized them with SDS and separated
the proteins by size using SDS-PAGE. A single polypeptide is
observed on both 7.5% (Fig. 7C) and 12.5% (data not shown)
gels that migrates with a mass >200 kDa consistent with the
mass of NuMA. Both immunofluorescence of the purified
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structures (Fig. 7B) and immunoblot using a NuMA-specific
antibody (Fig. 7D) confirm that this >200 kDa protein is
NuMA. In addition, immunoblot analysis shows that there is
no detectable tubulin or vimentin associated with these purified
structures (Fig. 7D). Using various quantities of bovine serum
albumin to estimate the staining sensitivities of these gels, we
have calculated that each isolated particle contains approximately 10 pg of NuMA, and that if any protein with ~66 kDa
molecular mass is associated with these structures then it is
present in no greater than a 1:10 molar ratio with NuMA (data
not shown). Thus, these data strongly suggest that these
isolated structures are composed exclusively of NuMA.
Following the isolation of these cytoplasmic structures, we
examined their morphology by TEM (Fig. 8). The purified structures are composed of a dense network of ~5 nm filaments that
appear to intersect at small electron dense foci. The morphology
of these purified structures is similar to the structures that are
formed in vivo in the absence of dynamic microtubules (i.e. in
the presence of either taxol or nocodazole), however, they have
a somewhat more extended filamentous appearance which may
be due to the initial assembly of these structures in the presence
of dynamic microtubules prior to their isolation by flow
cytometry. We do not observe either microtubules or the
prominent ~23 nm cables that are observed by TEM when
NuMA-∆NLS is expressed in the presence of dynamic microtubules. The failure to observe any of the ~23 nm cables in these
purified structures is consistent with the previous finding that the
tubulin associated with the structures in vivo is lost during the
isolation procedure (Fig. 7B,D), and that the ~23 nm cables form
through an interaction between NuMA-∆NLS and dynamic
microtubules (Figs 3 and 6). Collectively, these results demonstrate that NuMA is capable of assembling into a complex
structure in the cell cytoplasm that is composed of a network of
~5 nm filaments that are induced to form ~23 nm cables if it is
assembled in the presence of dynamic microtubules.
DISCUSSION
In this article we demonstrate that the intranuclear protein NuMA
assembles into an extensive filamentous network when expressed
in the cell cytoplasm. This network is composed of two types of
filamentous structures. One type of filament appears to result
from the inherent assembly properties of the NuMA protein
which leads to a highly branched, interlocking network of
filaments that are uniformly ~5 nm in diameter. The second type
of filament observed in these structures formed by NuMA-∆NLS
are solid, ~23 nm diameter, laterally asymmetric, unbranching
cables that result from the interaction between the network of
NuMA filaments and dynamic microtubules. The structures
formed by NuMA-∆NLS in the cell cytoplasm are stable to
extraction with non-ionic detergents and high salt concentrations
and behave as individual organelles when the cells are homogenized. To our knowledge, this type of filamentous organization
has not been previously documented for any cyto- or nucleoskeletal proteins of the cell, and is the first observation of the
extensive filamentous assembly of an intranuclear protein.
The finding that NuMA assembles into an extensive filamentous array in the cytoplasm is consistent with the prediction that
NuMA has a coiled-coil secondary structure, but contrary to the
structural predictions made using theoretical arguments (Parry,

1994) and a recent report examining the assembly properties of
the purified recombinant human NuMA protein in vitro
(Harborth et al., 1995). Harborth et al. (1995) reported that the
recombinant human NuMA protein purified from bacteria
following solubilization in 8 M urea assembled into ~200 nm
long parallel, in register, coiled-coil dimers that did not further
assembly into a filamentous array. The discrepancy between the
assembly products observed in vivo (this report) and those
obtained in vitro (Harborth et al., 1995) may be explained
through a number of technical considerations as explained by
Harborth et al. (1995) including the sub optimal buffer conditions used in vitro, the impaired renaturation of the protein
following denaturation in 8 M urea, impaired filament formation
due to the use of a bacterially expressed fusion protein, and/or
the potential need for post-translational modification. These
technical considerations are not applicable to the structures
described in this article because we are expressing the native
NuMA protein in the context of the normal cellular environment
(cytoplasmic localization notwithstanding), although it is
possible that in vivo conditions promote the higher-order
assembly of the simple dimeric NuMA molecules described by
Harborth et al. (1995) into the more complex arrangements of
NuMA described in this article. In any event, the products of the
higher-order assembly of NuMA in the cell cytoplasm are structurally unique relative to other cytoskeletal structures suggesting that in addition to the coiled-coil interactions that probably
lead to the formation of the ~5 nm filaments, NuMA assembles
into higher-order structures by a different mechanism compared
to conventional intermediate filament proteins (end-to-end associations rather than lateral associations as suggested by Parry
(1994), for example). It is also highly probable as we point out
below and as Harborth et al. (1995) concede that NuMA will
form a different structure depending on its interaction with additional cellular proteins. The interaction with additional cellular
proteins and/or the cell cycle-dependent nature of these filaments
may explain why we did not observe the formation of NuMAcontaining filaments in cells where post-mitotic nuclear protein
import was prevented by the microinjection of wheat germ
agglutinin (Compton et al., 1992).
What is the physiological role for the assembly of NuMA into
an extensive filamentous structure? We envision two potential
structural roles depending on the phase of the cell cycle. First,
NuMA may be serving a structural role inside the cell nucleus
during interphase. NuMA is a component of the nuclear matrix
(Kallajoki et al., 1991; Tang et al., 1993; Zeng et al., 1994a) that
has recently been localized to a subset of the core filaments of
the nuclear matrix (Zeng et al., 1994a). The core filaments of the
nuclear matrix have been observed by electron microscopy
following the extraction of chromatin-depleted nuclei with either
high salt (He et al., 1990) or electroelution (Jackson and Cook,
1988), and are a complex network of filaments with variable
diameters ranging from 9 to 13 nm that resemble the cytoplasmic intermediate filaments except that they are highly branching.
The highly branching organization of the filaments formed by
NuMA-∆NLS in the cell cytoplasm, the stability of these structures to high salt extraction, and the localization of NuMA to the
core filaments of the nuclear matrix (Zeng et al., 1994a) combine
to support the possibility that NuMA may be a structural
component of the nucleus and possibly a component of the core
filaments of the nuclear matrix. On the other hand, the diameter
of the filaments that are attributable to the assembly of NuMA

Filamentous assembly of NuMA
in the cell cytoplasm is only half the diameter of the core
filaments of the nuclear matrix. This discrepancy could be
explained if the core filaments of the nuclear matrix were heteropolymers composed of NuMA and some additional nuclear
protein(s) leading to the formation of filaments with different
dimensions compared to the filaments formed by NuMA alone
in the cell cytoplasm. Alternatively, NuMA may participate in
the formation of a filamentous structure within the nucleus that
is distinct from the core filaments of the nuclear matrix that have
been previously described. This alternative implies that there
may be multiple, potentially redundant filamentous networks
within the nucleus. The possibility of a redundant system of
intranuclear filaments has been previously suggested by Yang
and Snyder (1992) based on their findings that nuclei assemble
normally following mitosis despite the antibody-induced sequestration of NuMA in the cytoplasm.
The second potential physiological function for the extensive
filamentous assembly of NuMA is in organizing the microtubules at the polar ends of the mitotic spindle. We and others
have generated substantial experimental evidence indicating
that NuMA is required for the organization of the microtubules
at the polar ends of the mitotic spindle (Compton and Luo,
1995; Gaglio et al., 1995; Kallajoki et al., 1991, 1992; Yang
and Snyder, 1992), and the unique interaction between NuMA
and dynamic microtubules that we describe here may be related
to NuMA’s ability to organize the microtubules during mitosis.
However, the interaction between NuMA and microtubules is
distinct from the interactions between microtubules and more
conventional microtubule associated proteins (Olmsted, 1986;
Lee, 1993; Hirokawa, 1994) for several reasons. First, the 23
nm cables appear to be co-polymers containing both NuMA and
tubulin and are formed only when NuMA is expressed in the
cytoplasm in the presence of dynamic microtubules. These 23
nm cables do not form if microtubules are depolymerized by
nocodazole treatment or stabilized by taxol treatment. Second,
the cytoplasmic network of microtubules appears to be
consumed during the formation of these NuMA-tubulin
complexes. In some instances NuMA-∆NLS reaches expression
levels high enough that all of the tubulin is complexed in the
cytoplasmic mass formed by NuMA-∆NLS and the cytoplasmic network of microtubules is absent from the adjacent regions
of the cytoplasm (data not shown). This aspect of the formation
of the 23 nm cables is clearly different from the microtubule
binding properties of other microtubule binding proteins such
as MAP-2 and tau which crosslink microtubules and MAP-4
which coats the microtubule surface. Third, NuMA appears to
interact with the minus ends of the microtubules rather than the
microtubule surface or the plus ends of the microtubules located
at the cell periphery. Finally, the 23 nm cables formed by
NuMA and dynamic microtubules are solid and laterally asymmetric with the 5 nm NuMA filaments extending outward along
one surface. While a number of physical arrangements can be
proposed to account for all of these features, one possibility is
that NuMA interacts with (and perhaps destabilizes) the minus
end of the dynamic microtubule by inducing the microtubule to
open laterally into a curved sheet (Chretien et al., 1995) which
forms a trough to support the ordered packing of the NuMA
filaments. This highly speculative arrangement accounts for the
observations that the cables are ~23 nm in diameter, solid, and
laterally asymmetric. Regardless of the specific physical
arrangement of NuMA and microtubules within these 23 nm
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cables, however, the unique organization of these cables may
indicate that NuMA’s function as a component of the putative
mitotic spindle matrix is mechanistically involved in the organization of the microtubules of the mitotic spindle and/or in the
dynamic behavior of the microtubules in the mitotic spindle (i.e.
poleward microtubule flux). In conclusion, these results demonstrate that the compartmentalization of NuMA within the
nucleus may be necessary not only for a putative structural
function for NuMA, but also to prevent any untimely interaction between NuMA and microtubules which could deleteriously effect the dynamics of the cytoplasmic microtubules.
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